Search Results - "Abdelrahman, Kamal S."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
  2. 2
  3. 3

    Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation by Marzouk, Adel A., Abdel-Aziz, Salah A., Abdelrahman, Kamal S., Wanas, Amira S., Gouda, Ahmed M., Youssif, Bahaa G.M., Abdel-Aziz, Mohamed

    Published in Bioorganic chemistry (01-09-2020)
    “…[Display omitted] •A series of novel 1,6-dihydropyrimidin-2-thio was designed and synthesized.•Compounds 3a, 3b, 3e and 4b were selected for in vitro…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer’s diseases therapy by Soltan, Osama M., Abdelrahman, Kamal S., Bass, Amr K.A., Takizawa, Kazuki, Narumi, Atsushi, Konno, Hiroyuki

    Published in Bioorganic chemistry (01-10-2024)
    “…[Display omitted] •The HDACs ability to synergistically boost the performance of other anti-AD drugs, as well as the ease with which HDACs inhibitor cap group,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    A new application of isoindole fluorophore derivative in sitagliptin antidiabetic medication assay: Application to dosage forms and biological fluid evaluation by El Hamd, Mohamed A., Soltan, Osama M., Abdelrahman, Kamal S., Alsaggaf, Wejdan T., Abu‐hassan, Ahmed A.

    Published in Luminescence (Chichester, England) (01-06-2023)
    “…Dipeptidyl peptidase‐4 enzyme suppressant is a unique category of oral antidiabetic medication. Sitagliptin (STG) is a perfect member of this category and is…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10